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Abstract 
 
Parabens comprise a group of preservatives commonly added to cosmetics, lotions and other consumer products. 
Butylparaben has estrogenic and anti-androgenic properties and is known to reduce sperm counts in rats following 
perinatal exposure. Whether butylparaben exposure can affect other endocrine sensitive endpoints, however, remains 
largely unknown. In this study, time-mated Wistar rats (n=18) were orally exposed to 0, 10, 100 or 500 mg/kg bw/day 
of butylparaben from gestation day 7 to pup day 22. Several endocrine-sensitive endpoints were adversely affected. In 
the two highest dose groups, the anogenital distance of newborn male and female offspring was significantly reduced, 
and in prepubertal females, ovary weights were reduced and mammary gland outgrowth was increased. In male 
offspring, sperm count was significantly reduced at all doses from 10 mg/kg bw/day. Testicular CYP19a1 (aromatase) 
expression was reduced in prepubertal, but not adult animals exposed to butylparaben. In adult testes, Nr5a1 expression 
was reduced at all doses, indicating persistent disruption of steroidogenesis. Prostate histology was altered at prepuberty 
and adult prostate weights were reduced in the high dose group. Thus, butylparaben exerted endocrine disrupting effects 
on both male and female offspring. The observed adverse developmental effect on sperm count at the lowest dose is 
highly relevant to risk assessment, as this is the lowest observed adverse effect level in a study on perinatal exposure to 
butylparaben. 
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Introduction 1 
Parabens are preservatives commonly used in cosmetics and lotions, and some also in foods. Dermally applied parabens 2 
are absorbed by the skin and metabolized by esterases, conjugated and excreted in urine and bile (reviewed by Soni et 3 
al., 2005). Although metabolism following dermal and oral exposure is rapid, toxic effects have been reported in 4 
experimental studies on oral exposure to some parabens, including butylparaben. 5 
Some parabens have estrogenic properties both in vitro and in vivo, and butylparaben has been shown to affect 6 
endocrine-sensitive organ systems (Boberg et al., 2010). Studies on juvenile rats exposed to butylparaben have shown 7 
conflicting results, as reduced sperm count and testosterone level reported in one study at doses from 10 mg/kg bw/day 8 
(Oishi et al,. 2001) was not corroborated by  subsequent studies investigating similar dose levels (Hoberman et al., 9 
2008, Gazin et al., 2013).   10 
Stronger evidence is found regarding effects on sperm count after developmental exposure to parabens (Kang et al., 11 
2002; Zhang et al., 2014; Yang et al., 2015).  Reduced epididymal sperm count and motility were seen in rat offspring 12 
of dams exposed subcutaneously to 100 and 200 mg butylparaben/kg bw/day during gestation and lactation (Kang et al., 13 
2002). In a recent study, perinatal exposure of rats to 2.5 mg/kg bw/day of isobutylparaben reduced epididymal sperm 14 
count and motility compared to control (Yang et al., 2015). In another rat study, oral exposure to n-butylparaben at 15 
doses of 0, 64, 160, 400 and 1000 mg/kg/day from gestation day (GD) 7 to postnatal day (PND) 21 led to reduced male 16 
anogenital distance at PND 1 and 21, delayed preputial separation, reduced reproductive organ weights at several ages, 17 
and reduced epididymal sperm count at PND 90 at the two highest dose levels (Zhang et al., 2014). These effects were 18 
associated with reduced testosterone and LH levels, and elevated estradiol and progesterone levels in serum from 19 
prepubertal male rats, supporting the view that butylparaben can exert both anti-androgenic and estrogenic effects on 20 
the developing organism.  The underlying mechanisms for the effect on sperm count remain unknown, but in addition to 21 
estrogenic properties (Byford et al., 2002; Routledge et al., 1998), in vitro studies have shown inhibition of androgen 22 
receptor activation by butylparaben (Satoh et al., 2005; Chen et al., 2007).  23 
Little is known about effects of butylparaben on other endocrine sensitive endpoints such as prostate and mammary 24 
gland development. Estrogenic chemicals have been shown to affect early mammary gland development in female 25 
rodents and to accelerate mammary gland growth. For instance, an increase in outgrowth and number of terminal end 26 
buds (TEBs) in prepubertal female rat mammary glands have been shown after exposure to estrogenic compounds such 27 
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as ethinyl estradiol and genistein (Mandrup et al., 2012; Mandrup et al., 2015; Cotroneo et al., 2002). These findings 28 
may predict adverse effects on human breast development and possibly increased risk of breast cancer following early 29 
exposure to estrogenic chemicals (Soto et al., 2013).  Animal studies have shown that developmental exposure to 30 
endocrine disrupting compounds, or elevated perinatal levels of estrogens, can induce atypical hyperplasia of the 31 
prostatic epithelium, as well as morphological changes resembling those of precancerous lesions in humans (PIN 32 
lesions) (Prins et al., 2007).  33 
Due to the endocrine disrupting activity of butylparaben, a possible influence on prostate and mammary development 34 
can be hypothesized, and hence this study aimed to investigate developmental effects of butylparaben on these organs in 35 
prepubertal and adult offspring. We also intended to improve risk assessment of butylparaben by investigating 36 
endocrine sensitive endpoints in perinatally exposed rats at doses from 10 mg/kg bw/day, and to elucidate the 37 
mechanisms underpinning the influence of butylparaben on sperm count.  38 
Materials and methods 39 
Test compounds 40 
Butylparaben (purity >99.0 %, CAS no. 94-26-8) was purchased from Sigma-Aldrich (Brøndby, Denmark). Corn oil 41 
was used both as a control compound and vehicle and purchased from Sigma (Brøndby, Denmark). 42 
Animals and exposure 43 
72 time-mated nulliparous, young adult Wistar rats (HanTac:WH, SPF, Taconic Europe, Ejby, Denmark) were supplied 44 
at day 3 of pregnancy. The day when a vaginal plug was detectable was designated as gestation day (GD) 1 and the 45 
expected day of delivery, GD 23 was designated as pup day (PD) 1. The study was performed in 2 blocks of 36 dams 46 
(separated by one week), and all dose groups were equally represented in both blocks. The animal experiment was 47 
carried out at the DTU National Food Institute (Mørkhøj, Denmark). Ethical approval was obtained from the Danish 48 
Animal Experiments Inspectorate: authorization number, 2012-15-2934-00089 C4. The experiments were overseen by 49 
the National Food Institutes in-house Animal Welfare Committee for animal care and use. 50 
 51 
The dams were housed in pairs until GD 17 and alone thereafter under standard conditions in semi-transparent 52 
polysulfone (PSU) cages (PSU 80-1291HOOSU Type III, Tecniplast) (15 x 27 x 43cm) with aspen wood chip bedding 53 
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(Tapvei, Denmark), Enviro Dri nesting material (Brogaarden, Lynge, Denmark) and aspen wood shelters Tapvei Arcade 54 
17 (Brogaarden, Lynge, Denmark). The polysulfone bottles and cages, as well as the aspen wood shelters (instead of 55 
polycarbonate) were used to reduce the risk of migration of bisphenol A that potentially could confound the study 56 
results. The animal room had controlled environmental conditions with a 12 hour light/dark cycle with light intensity 57 
500 lux starting at 9 pm, humidity 55 % ± 5, temperature at 21°C ± 1°C and ventilation changing air 10 times per h. All 58 
animals were fed on a standard diet with ALTROMIN 1314 (soy- and alfalfa-free, ALTROMIN GmbH, Lage, 59 
Germany). Acidified tap water (to prevent microbial growth) in polysulfone bottles (84-ACBTO702SU Tecniplast) 60 
were provided ad libitum.  After weaning, offspring were housed in pairs.  61 
The day after arrival (GD 4), time-mated dams were distributed into 4 groups of 18 rats with similar body weight (bw) 62 
distributions. The dams received vehicle (controls), or 10, 100 or 500 mg/kg bw/day of butylparaben. Test compounds 63 
and vehicle were administered by oral gavage with a stainless steel probe 1.2 x 80 mm (Scanbur, Karlslunde, Denmark) 64 
once daily in the morning from GD 7 to the day before expected birth (GD 21) and again after birth from PD 1 to 22 at 65 
a constant volume of 2 ml/kg bw per day. Dams that did not give birth were omitted from the study. The exposure 66 
period was chosen to cover the most sensitive windows of reproductive development in rat offspring. The individual 67 
doses were based on the body weight of the animal on the day of dosing. The dams were inspected twice a day for 68 
general toxicity including changes in clinical appearance. Body weights were recorded on GD 4 and daily during the 69 
dosing period to monitor changes in weight gain, to follow pregnancy status and to adjust dose according to weight.  70 
In vivo measurements 71 
The day after delivery the pups were counted, sexed, weighed, and checked for anomalies. Dead pups were investigated 72 
macroscopically for pathological changes when possible. Anogenital distance (AGD) was measured in all offspring 73 
using a stereomicroscope with unit markings on the ocular. All offspring were weighed on PD 6. On PD 14, all male 74 
and female pups were weighed and examined for number of areolas/nipples (NR), described as a dark focal area (with 75 
or without a nipple bud) located where nipples are normally present in female offspring. The same skilled technician, 76 
blinded with respect to exposure groups, recorded both AGD measurements and NR counts. After weaning of the 77 
offspring at PD 22, the dams were killed and the number of implantation sites was registered to calculate post-78 
implantation and perinatal loss. 79 
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Pubertal onset was assessed by determining day of vaginal opening or the day of balano-preputial separation in weaned 80 
female and male offspring, respectively. Registrations were performed daily in females from PD 27 until vaginal 81 
opening was detected in all animals. Males were examined daily from PD 39 until the last male was positive. Age and 82 
body weight of the rats were recorded on the day in which vaginal opening and balano-preputial separation was first 83 
observed. Onset of puberty was assessed blinded with respect to exposure groups by skilled technicians.  84 
  85 
Necropsy of male and female offspring PD 16/17 and 22 86 
Reproductive organ weights and histological and gene expression changes in reproductive organ weights were 87 
examined at PD 16 (males) and 17 (females), as this age has proved sensitive for detection of particularly anti-88 
androgenic effects of chemicals (Metzdorff et al., 2007; Christiansen et al., 2009). On PD 16 and 17, one male and one 89 
female pup from each litter (n=12-18) were weighed and decapitated, and blood was collected in heparinized tubes for 90 
hormone analysis. From males the following organs were excised and weighed: Testes, ventral prostate, epididymis, 91 
seminal vesicle, levator ani/bulbocavernosus muscle (LABC), bulbourethral gland, liver, adrenal, and retroperitoneal fat 92 
pad. From females the following organs were excised and weighed: Ovary, liver, thyroid, and retroperitoneal fat pad. 93 
One testis per pup was placed in RNAlater for gene expression studies as described below). 94 
On PD 22, one female and one male pup per litter (n=12-14) were weighed and decapitated, and blood was collected in 95 
heparinized tubes for hormone analysis. From females, ovaries were excised and weighed, and from males testes and 96 
ventral prostate were excised and weighed. Testes were fixed in Bouin’s fixative overnight and ventral prostates were 97 
fixed in formalin for histological examination. Mammary glands were dissected from female pups for whole mounting. 98 
The tissue was dissected in order to include the abdominal (4
th
) mammary gland with the adjacent lymph nodes and part 99 
of the inguinal (5
th
) mammary gland. At PD 22 the number of terminal end buds (TEBs) in rat mammary glands is 100 
peaking, and this age is considered sensitive to detection of changes in early mammary development (Russo et al., 101 
1979; Mandrup et al., 2012). 102 
Necropsy of adults and epididymal sperm count 103 
Approximately one female and one male pup per litter were sacrificed at PD 80 to 90 and body weights were 104 
determined. From males the following organs were excised and weighed: Testes, epididymis, seminal vesicle with 105 
prostate, ventral prostate (separated from dorsolateral prostate and seminal vesicle) levator ani/bulbocavernosus muscle, 106 
bulbourethral gland, liver, thyroid, 4
th
 mammary gland, and retroperitoneal fat pad. One testis per animal was fixed in 107 
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Bouin’s fixative overnight, and the contralateral was frozen for gene expression studies. Epididymides, ventral prostates 108 
and mammary glands were fixed in formalin for histological examination. 109 
For sperm count analysis, samples were analyzed using computer assisted sperm analysis (CASA) system (HTM-IVOS, 110 
Hamilton Thorne Research, MA, USA). From male offspring, alternately left or right cauda epididymis including 1 cm 111 
of ductus deferens was frozen in liquid nitrogen and stored at -80°C for sperm count analysis. The cauda epididymis 112 
was thawed, weighed and prepared as described by Jarfelt et al. (2005), and samples were analyzed using a 10 × UV 113 
fluorescent objective and IDENT OPTIONS on the CASA. Ten fields were analyzed for each sample and three counts 114 
were performed for each suspension. Counts were averaged and data are presented as number of sperm per gram cauda. 115 
Sperm cell motility and morphology was not investigated.   116 
Females were sacrificed on the day of estrous as judged from a vaginal smear in the morning. The following organs 117 
were excised and weighed: Ovaries, uterus, liver, thyroid, mammary glands (4th gland), and retroperitoneal fat pad. 118 
Abdominal (4
th
) mammary glands, ovaries and uteri were fixed in formalin for histological examination. 119 
Hormone analysis and gene expression 120 
Serum estradiol was measured in 8 to 10 plasma samples per dose group in PD 16 males and PD 22 females using 121 
Enzyme Linked Assay (Cayman kit no. 582251, Bertinpharma, Montigny-le-Bretonneux, France).    122 
Gene expression analyses were performed on testes PD 16 (n=9-10) and PD 90 (n=4) by RT-qPCR. Protocols and 123 
verification of suitable reference genes for data normalization were as previously described (Svingen et al., 2015). 124 
Briefly, total RNA was extracted from the entire testis at PD16 or approximately 120 mg tissue (median cross-section) 125 
at PD90 using an RNA Mini kit (Qiagen), including on-column DNAse I treatment. RNA was subsequently quantified 126 
and purity-verified on a nano-drop spectrophotometer and 500 ng total RNA used to synthesize cDNA (Omiscript kit; 127 
Qiagen) in the presence of 6µM Random Primer mix (New England Biolabs). cDNA was diluted 1:20 and used at 3 µl 128 
per RT-qPCR reactions. TaqMan Gene Expression Assays (Life Technologies) were: Ddx4 (Rn01489814_m1), Fshr 129 
(Rn01648507_m1), Hsd3b1 (Rn01774741_m1), Lhr (Rn00564309_m1), Nr5a1 (Rn00584298_m1), Sox9 130 
(Rn01751069_mH), Cyp19a1 (Taxvig et al., 2008) and Ar, Cyp11a1, Cyp17a1 (Laier et al., 2006). RT-qPCR assays 131 
were run on a 7900HT Fast Real-Time PCR System (Applied Biosystems) over 45 cycles using a two-step cycling 132 
protocol with annealing temp at 60 °C. Relative transcript abundance was calculated by the comparative Ct-method 133 
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using the reference genes Rpl13a (Rn00821946_g1) and Sdha (Rn00590475_m1). Intra-assay variability of technical 134 
replicates was <0.5 cycles.  135 
Mammary whole mounts 136 
Mammary glands from PD 22 female offspring were placed on a glass slide and stained with alum carmine as described 137 
in Mandrup et al., 2015. Briefly, the whole mounts were scanned on a flatbed scanner (4800 dpi) and mammary 138 
development was assessed on the digital images. Measurements were performed in Image Pro Plus 7.0 software (Media 139 
Cybernetics, Bethesda, MD, USA). The glands were evaluated for outgrowth and extent of mammary development. For 140 
each dose group, 12 to 14 samples were evaluated. Outgrowth was assessed by measuring the outer area, longitudinal 141 
growth, transverse growth, distance to the lymph node (shortest distance from the 4
th
 gland to the adjacent lymph node) 142 
and distance to the 5
th
 gland (shortest distance from the 4
th
 to the 5
th
 abdominal mammary gland). The number of 143 
terminal end buds was counted (TEBs, defined as tear-drop shaped buds in zone C with a diameter of 100 µm or more, 144 
as defined by Russo and Russo, 1996a). 145 
 146 
Histological examination 147 
Female mammary glands PD 80-90 were sectioned and stained with haematoxylin and eosin by standard procedures. 148 
Histologic evaluation included ductular changes, lobular changes and functional changes in females confirmed to be in 149 
oestrous. Ductular changes included the evaluation and distribution of intraductal hyperplasia (defined as duct 150 
epithelium with 3 or more layers of epithelial cells as described by Singh et al., 2000). Evaluation of lobular changes 151 
included lobule types (as single alveoli/ lobules smaller than type 1, lobules type 1 or lobules type 2 as defined by 152 
Russo et al., 1996a for humans) and lobuloalveolar structure of the lobules (loss of the typical tubuloalveolar 153 
architecture of alveoli). Finally, the distribution of secretory material in the ducts was evaluated as a sign of secretory 154 
activity. 155 
Ovary histology was examined in one section from all adult females from the control and high dose groups and focused 156 
only on health status and cyclic activity. No quantitative measures were made. Uterine histology was examined only to 157 
confirm estrous cycle stage to aid the histological examination of mammary glands. 158 
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Histological examination of one section per organ (testes, epididymides and ventral prostate) was performed in all adult 159 
males from the high dose and control groups. A detailed qualitative examination of the testes was performed taking into 160 
account the tubular stages of the spermatogenic cycle to identify effects such as missing germ cell layers or types, 161 
retained spermatids, multinucleate or apoptotic germ cells and sloughing of spermatogenic cells into the lumen. 162 
Epididymides were evaluated for ductal atrophy, changes in sperm content and presence of sloughed testicular germ 163 
cells and cell debris in the epididymal lumen. Ventral prostates of adult males were evaluated with regard to degree of 164 
inflammation, epithelial atrophy, and atypical hyperplasia. Additionally, morphometric examination was made in 165 
ventral prostate from adult and prepubertal (PD 22) males to identify possible changes in the relative areas of different 166 
compartments. Each area was applied a grid with 15 points that were manually assigned as epithelium, stroma, lumen or 167 
outside tissue section/undefined. This was done in 10 randomly selected areas per tissue section under 20x or 10x  168 
magnification (PD 22 and 90, respectively) using Image-Pro1 Plus ver. 7.0 (Media Cybernetics, Inc., USA). The 169 
percentage of areas occupied by each compartment (epithelium, stroma, and lumen) was compared between exposed 170 
groups and controls, and the ratio between epithelium and lumen was calculated and compared between groups. Grid 171 
points outside the tissue or undefined were not included in the statistical analysis. 172 
 173 
Statistics   174 
GraphPad Prism 5 was used for analysis of gene expression data and morphometrical data, whereas SAS Enterprise 175 
Guide 4.3 was used for all other data. 176 
Data from continuous endpoints were examined for normal distribution and homogeneity of variance, and if relevant, 177 
log transformed. Data with normal distribution and homogeneity of variance were analyzed using analysis of variance 178 
(ANOVA) followed by Dunnett’s multiple comparison test. Organ weights were analyzed using body weight as a 179 
covariate. When more than one pup from each litter was examined, statistical analyses were adjusted using litter as an 180 
independent, random and nested factor in ANOVA or litter means were used. In cases where normal distribution and 181 
homogeneity of variance could not be obtained by data transformation (i.e. whole mount measurements), a non-182 
parametric Kruskall-Wallis test was applied followed by Dunn’s multiple comparison test comparing exposed groups 183 
with controls. 184 
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AGD and organ weights were analyzed using body weight as a covariate. The number of nipple/areolas was assumed to 185 
follow a binomial distribution with a response range between 0 and θmax, with θmax being equal to the biologically 186 
possible maximal number of nipples in rats, either 12 or 13. The choice of θmax was decided on considering the global 187 
fit (information criterion of Schwarz). To account for litter effects on nipple retention, correlation structures between 188 
number of nipple/areolas and litter were modelled by the Generalized Estimating Equations method using the SAS 189 
procedure PROC GENMOD. 190 
Histological scoring data were evaluated using the 2x2 Fisher's Exact Test without correction for multiple comparisons. 191 
Results 192 
Dams and delivery 193 
Exposure to butylparaben did not affect maternal body weight gain, gestation length, litter size, pre- or perinatal 194 
offspring survival, or body weights either at birth or in the postnatal period (Table 1).   195 
In vivo markers of endocrine disrupting effects 196 
Endocrine-disrupting effects of butylparaben were seen in neonatal pups, as AGD (analyzed with body weight as a 197 
covariate) was reduced dose-dependently in both males and females at PD 1 following perinatal exposure to 100 or 500 198 
mg/kg bw/day (Fig. 1 and Table 1). No significant effects were seen for male nipple retention (Table 1). 199 
Sexual maturation, measured as day of vaginal opening (VO) in females and day of preputial separation (PPS) in males 200 
occurred slightly later in both male and female offspring exposed to butylparaben, but this was not statistically 201 
significant (Table 1). 202 
Organ weights, epididymal sperm counts and histology 203 
No effects of butylparaben on the body weight of offspring were seen on PD 16, 17, 22 or in adulthood. In male 204 
offspring, no changes in reproductive organ weights were detected at PD 16 or 22 (Table 2). In female offspring, ovary 205 
weights were reduced dose-dependently at PD 17, and the effect was statistically significant at 100 and 500 mg/kg 206 
bw/day (Fig. 1; Table 2). Ovary weights were slightly higher compared to controls at PD 22, but this was not 207 
statistically significant (p=0.086 at high dose) (Table 2).  208 
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In adult males (PD 90), the weight of prostate and seminal vesicle (together) and the weight of ventral prostate 209 
(separated from seminal vesicle) were reduced in the highest dose group compared to controls (p=0.015 and p=0.05, 210 
respectively) (Fig. 1; Table 2). Epididymal weight was significantly increased in the middle dose group only (p=0.01) 211 
(Table 2), and epididymal sperm count was significantly decreased in all dosed groups compared to the controls (p < 212 
0.0001) (Fig. 3).The histological examination of testes and epididymides from adult controls and high dose males 213 
showed no differences between groups.  214 
No other effects were seen on adult male or female organ weights (Table 2). 215 
Testicular gene expression  216 
At PD 16, Cyp19a1 expression was significantly lower in testes from all exposure groups compared to controls (Fig. 217 
2a). There was a tendency towards highest levels of exposure showing lowest level of expression; relative mRNA levels 218 
were 33%, 30% and 23% that of control group for 10, 100 and 500 mg/kg bw/day groups, respectively. Expression level 219 
of several cell-specific marker genes was unchanged at PD16 following exposure to butylparaben. The germ cell marker 220 
Ddx4 was unchanged in all groups, suggesting that germ cell numbers were unchanged (Fig. 2a). The Sertoli cell 221 
markers Sox9 and Fshr showed stable expression across groups, indicating that, at least Sertoli cell numbers were 222 
unaffected by exposure (Fig. 2a). So too, the Sertoli/Leydig cell marker Nr5a1 and Ar were unchanged, as were all the 223 
Leydig cell markers Lhr, Cyp11a1, Cyp17a1 and Hsd3b1 (Fig. 2a).   224 
In adult testes, Cyp19a1 expression was similar in exposed and control animals. All other marker genes were also 225 
unchanged except Nr5a1, which was lower than controls in all exposed groups (Fig. 2b).  226 
Histological examination of prostate  227 
In ventral prostates of prepubertal males, morphometric analysis showed that the epithelial area (Fig. 4A) and the ratio 228 
between epithelium and lumen (Fig. 4B) were decreased in the middle dose group compared to controls.  At this age, 229 
most prostates had small acini with columnar epithelium and an abundant amount of secretory material in the apical part 230 
of the cells (Fig. 4C), whereas animals with a low ratio between epithelium and lumen had an increased incidence of 231 
large acini with cuboidal epithelium (Fig. 4D).  232 
Adult ventral prostate histology differed markedly between individuals, but this was not dose related. Several animals 233 
showed variable degree of inflammation in the ventral prostate, consisting of focal or diffuse accumulation of 234 
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mononuclear cells. We observed no difference between groups in total numbers of animals with interstitial 235 
inflammation (5 out of 16 controls and 7 out of 18 high dose animals), nor between groups in scores for degree of 236 
inflammation (data not shown). In some cases, the epithelium adjacent to inflammatory foci showed minor reactive 237 
hyperplasia with cellular atypia (4 out of 16 controls and 6 out of 18 high dose animals). There was no difference 238 
between groups in scores for epithelial height, and morphometric analysis of the ratio between luminal area and 239 
epithelial area showed no differences between dose groups at PD 90 (data not shown).  240 
Dorsolateral prostate showed a much lower incidence of inflammatory foci than ventral prostate, with small 241 
inflammatory foci only seen in 2 controls and 1 high dose animal. Dark granules in epithelial cell cytoplasm or nuclei 242 
were seen in several areas of dorsolateral prostate for some animals, but no difference in incidence was seen between 243 
dose groups (7 out of 16 controls and 5 out of 18 high dose animals affected). 244 
Mammary gland development and histology in female offspring 245 
Prepubertal mammary glands were affected by perinatal exposure to butylparaben. At PD 22, female mammary glands 246 
showed a significantly higher number of terminal end buds (TEBs) in the two highest dose groups compared to controls 247 
(Fig. 4F-H). Indications of increased outgrowth towards the lymph node was seen, as the distance between mammary 248 
tissue and lymph node was significantly reduced in females exposed to 100 mg/kg bw/day of butylparaben compared to 249 
control females (Fig. 4E). 250 
No clear effect of butylparaben was seen on mammary glands of adult female offspring. However, more females 251 
displayed delayed differentiation of the adult mammary glands and increased proliferation of duct epithelium in the 252 
lowest dose group compared to controls, but this was not statistically significant. Five out of 13 females from the low 253 
dose group had less developed lobules (lobules smaller than type 1) compared to 1 of 14 females from the control group 254 
(p=0.08 in 2x2 Fisher). Three out of 13 females had intraductal hyperplasia (>30% of tissue) in the low dose group, 255 
whereas no controls had intraductal hyperplasia (p=0.1 in 2x2 Fisher) (Fig. 4I-J). No sign of secretory activity or 256 
changes in tubuloalveolar morphology of the lobules were observed.  257 
Histological examination of ovaries  258 
The histological examination of ovaries from adult controls and high dose females showed apparently healthy ovaries 259 
with presence of all stages of follicles and with an abundant number of corpora lutea (data not shown).  260 
 at D
TU
 Library on A
pril 28, 2016
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
13 
 
Serum hormone levels 261 
Serum estradiol levels were examined at PD 16 in males and at PD 22 in females, i.e. time points when we observed 262 
effects that may be related to altered estradiol production (reduced aromatase gene expression in testes and increased 263 
female mammary outgrowth). No effects of treatment were observed at these time points. 264 
Discussion 265 
Butylparaben is known to affect sperm count in rat offspring, but until now knowledge on other reproductive endpoints 266 
has been lacking. In this study we found endocrine disrupting effects in both male and female offspring after perinatal 267 
exposure of rats, including shortened AGD, reduced sperm count and reproductive organ weight, disrupted gene 268 
expression in the testes, and abnormal mammary gland development. Of particular importance for risk assessment is the 269 
observation that the sperm count was lower at all doses, starting at 10 mg/kg.  270 
Mechanisms of actions for effects on the male reproductive system 271 
We observed a reduction in epididymal sperm count, which corroborates previous findings in rat offspring following 272 
subcutaneous exposure of dams to 100 and 200 mg/kg bw/day of butylparaben (Kang et al., 2002), or oral exposure to 273 
400 and 1000 mg/kg bw/day (Zhang et al., 2014). Table 3 summarizes findings in rat studies with perinatal exposure to 274 
butylparaben or  isobutylparaben. Zhang et al., 2014, did not see any changes in sperm counts at the dose levels applied 275 
in the current study, although rat strain and study design were comparable. To some extent, our findings of effects at 276 
relatively low oral doses are supported by a study showing reduced sperm count and motility in rats perinatally exposed 277 
to 2.5 mg/kg bw/day of the structurally related isobutylparaben (Yang et al., 2015).   278 
In the current study, a shortened neonatal male AGD was seen from 100 mg/kg bw/day, but the same was only seen at 279 
doses from 400 mg/kg bw/day of butylparaben in the study by Zhang et al., 2014, and not in the study by Kang et al., 280 
2002 (see Table 3).In a previous study we showed that subcutaneous exposure of pregnant dams to 200 or 400 mg/kg 281 
bw/day of butylparaben did not affect AGD or testicular testosterone synthesis in fetal male rats (Taxvig et al., 2008). 282 
Shortened male AGD is often considered an indicator of anti-androgenicity, fitting with the known anti-androgenic 283 
effects of butylparaben in vitro (Satoh et al., 2005; Chen et al., 2007). Notably, the present study showed a shallow 284 
dose-response relationship between butylparaben exposure and male AGD with a maximum decrease of only 7%. A 285 
comparably shallow dose-response curve was seen in a recent study on bisphenol A (Christiansen et al. 2014). In 286 
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contrast, no change in male AGD was seen after perinatal exposure to the potent estrogen ethinyl estradiol (Mandrup et 287 
al., 2013). These findings may suggest that some chemicals with a common profile of estrogenic and weakly anti-288 
androgenic effects only induce subtle effects on AGD. 289 
To gain further insight into potential mechanisms behind the effects on male reproductive development, we analyzed 290 
the expression of several genes in prepubertal and adult testes. Several cell-specific marker genes were unchanged both 291 
at PD16 and adulthood, suggesting that the general testis cellularity was maintained. However, at PD16 the expression 292 
of Cyp19a1 (aromatase) was lower in all dose groups compared to controls. CYP19 catalyzes the conversion of 293 
androgens into estrogens (Simpson et al., 2002), and at this stage aromatase is expressed by immature rat Sertoli cells 294 
and is stimulated by FSH to elevate serum estradiol for a few days (Picut et al., 2015). The role of estradiol at this age is 295 
not clear, but the increase in estradiol coincides with the first wave of spermatogenesis and establishment of the blood-296 
testis barrier. Therefore, it may be speculated that the reduction of aromatase levels at this stage is related to the 297 
observed low sperm count later in life. Alternatively, our findings may reflect a slight delay in development of the 298 
exposed rats. Although butylparaben did not appear to affect estradiol synthesis or secretion at this age, it would be 299 
interesting to further scrutinize possible effects of butylparaben on testicular aromatase levels and estradiol production.  300 
In adult testes we observed a reduction in Nr5a1 expression in exposed animals. Nr5a1 encodes a nuclear receptor 301 
commonly called Steroidogenic Factor-1 (SF-1), which is involved in the regulation of numerous genes, including 302 
several steroidogenic factors (Buaas et al., 2012).  Thus, reduced NR5A1 could help explain alterations in hormone 303 
levels observed in adulthood in the study by Zhang et al. (2014). Actually, albeit not statistically significant, Cyp17a1 304 
showed a slightly lower expression in the same testes displaying reduced Nr5a1 levels, which is in line with the known 305 
involvement of NR5A1 in the transcriptional regulation of several CYP genes, including Cyp17. Therefore, 306 
butylparaben exposure could be suggested to compromise reproductive function by interfering with steroidogenesis. 307 
However, butylparaben had no or limited effects on estradiol or testosterone levels adrenal H295R cells (Taxvig et al., 308 
2008).     309 
The observed reduction in prostate and seminal vesicle weight in adult animals may also be a consequence of altered 310 
hormone production early or late in life. Indications of early changes in prostate development were seen as the relative 311 
epithelial area in PD 16 prostates was reduced at 100 mg/kg bw/day compared to controls, but we found no histological 312 
changes in prostates of young adults after butylparaben exposure. It is well known that developmental exposure to other 313 
estrogenic chemicals or elevated perinatal levels of estrogens in rodents can induce atypical hyperplasia of the prostatic 314 
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epithelium (PIN lesions) and morphological changes resembling those of precancerous lesions in humans (reviewed by 315 
Prins et al., 2007). Focal proliferative effects are, however, unlikely to be reflected by prostate weights. But neonatal 316 
exposure to high doses of estradiol benzoate in rats was found to induce prostatic PIN lesions and reduced dorsal 317 
prostate weight later in life (Ho et al., 2006). Therefore, despite being indicative, our data on prostate weights alone 318 
does not allow us to conclude whether proliferative effects were induced by butylparaben or not, nor does it lend 319 
enough insight to elucidate possible effects of parabens on prostate cancer susceptibility. For this, further examination 320 
in older animals or in a cancer induction model is necessary.  321 
Altered female reproductive development 322 
The fact that prepubertal female rats exposed to butylparaben displayed increased outgrowth of mammary glands and a 323 
greater number of terminal end buds (TEBs) supports an estrogenic mode of action. Similarly, an increase in mammary 324 
gland outgrowth in female rats has been seen with perinatal exposure to ethinyl estradiol or a mixture of estrogenic 325 
chemicals (Mandrup et al., 2012; Mandrup et al., 2015), and with prepubertal exposure to the phytoestrogen genistein 326 
(Murill et al., 1996). Early postnatal exposure to phytoestrogens or bisphenol A can increase the number of TEBs in 327 
prepubertal rats (Tan et al., 2004, Moral et al., 2008). In our previous study on ethinyl estradiol, we observed no change 328 
in TEB numbers in females, but an increase in male TEB numbers (Mandrup et al., 2012). TEBs are the site of origin of 329 
mammary carcinomas and a target structure of carcinogens (Russo et al., 1979; Russo and Russo, 1996b), and a link 330 
between chemically induced increases in TEB numbers and an increased risk of mammary cancer has been proposed 331 
(Fenton, 2006). In adult mammary gland, possible effects on intraductal hyperplasia and reduced lobular development 332 
were observed at 10 mg/kg bw/day, but the low incidence of intraductal hyperplasia and the lack of effect at higher 333 
doses complicate the interpretation of these findings. Interestingly, intraductal hyperplasia has also been observed at 334 
low doses of bisphenol A (Murray et al., 2007, Durando et al., 2007), emphasizing that some endocrine disruptors may 335 
induce proliferative changes in the mammary ducts at low, but not high doses (Murray et al., 2007, Vandenberg et al., 336 
2013, Mandrup et al. submitted). It may be speculated that the observed changes in early mammary development may 337 
be related to adverse effects later in life, but further studies are needed to clarify this. 338 
The observed reduction in prepubertal ovary weight is in agreement with a study on neonatal rats showing delayed 339 
follicular recruitment at PD 8 after 7 days of subcutaneous exposure to propyl- and butylparaben (Ahn et al., 2012). In 340 
our study, adult ovaries appeared normal, but it may be speculated that a possible interference with early follicle 341 
recruitment may have long-term adverse effects manifesting as altered reproductive function later in life. Currently, few 342 
 at D
TU
 Library on A
pril 28, 2016
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
16 
 
studies have targeted the influence of chemicals on early ovarian development. One example of altered early ovary 343 
development with late-life consequences following exposure to a weak estrogen is the finding of inhibited germ cell 344 
nest breakdown on PND 4 and an early decline in fertility in mice prenatally exposed to low doses of bisphenol a 345 
(Wang et al., 2014). 346 
Few studies have reported changes in female AGD at birth, but we observed a slight reduction in female pup AGD 347 
(corrected for body weight changes) following butylparaben exposure in this study and with bisphenol A exposure in a 348 
previous study (Christiansen et al., 2014). In contrast, ethinyl estradiol increased the AGD and the number of retained 349 
nipples of female offspring (Mandrup et al., 2013). Moreover, prochloraz exposure in utero increased female AGD in 350 
several studies (Laier et al., 2006; Melching-Kollmuss et al., 2016). Different effect patterns thus appear for weak and 351 
strong estrogens, but little is known regarding the relevance of these findings and whether such disruptions to endocrine 352 
homeostasis can predict any late life reproductive dysgenesis in females.  353 
Implications for risk assessment 354 
We found that both prepubertal aromatase expression and adult sperm count were affected at the lowest administered 355 
dose of butylparaben. This corresponds to the dose level previously shown to affect sperm count following juvenile 356 
dietary exposure in rats (Oishi 2001), but disagreeing with two other studies on butyl- and propylparaben, respectively 357 
(Hoberman et al., 2008, Gazin et al., 2013). Due to these discrepancies, it has been difficult to determine a robust no-358 
adverse effect level (NOAEL) for risk assessment. The Scientific Committee of Consumer Safety applied a no-effect 359 
level (NOEL) of 2 mg/kg bw/day in their risk assessment of butylparaben (SCCS 2013). This was based on the lack of 360 
effect on epididymis following juvenile subcutaneous exposure (Fisher et al. 1999). In their opinion, SCCS considered 361 
that this starting point for risk assessment was a “conservative choice”. However, the current data suggest that a 362 
NOAEL of 2 mg/kg bw/day is not conservative, as the observed reductions of epididymal sperm count and testicular 363 
aromatase expression at 10 mg/kg bw/day points to a NOAEL at or possibly below 2 mg/kg bw/day. This is further 364 
corroborated by the recent finding of reduced sperm count and motility in rats perinatally exposed to 2.5 mg/kg bw/day 365 
of the structurally related isobutylparaben (Yang et al., 2015). 366 
The SCCS discussed that rats may be a poor model for assessing and extrapolating potential harmful effects of 367 
butylparaben in humans, as rats have a much greater metabolic rate. For instance, internal exposure levels of free 368 
parabens measured in human males exposed dermally to 10 mg/kg bw/day were similar to internal exposure of rats 369 
 at D
TU
 Library on A
pril 28, 2016
http://toxsci.oxfordjournals.org/
D
ow
nloaded from
 
17 
 
exposed orally to 1000 mg/kg bw/day (Appendix 2 of SCCS 2013). Therefore, the SCCS noted that when using 370 
toxicokinetic data, it is uncertain whether the desired margin of safety of 25 can be achieved and thus, that uncertainties 371 
with risk assessment remain which presently cannot be resolved (SCCS 2013). Notably, blood levels of parabens do not 372 
directly reflect levels in solid tissues. Examination of tissue distribution of C14-labelled butylparaben and metabolites 373 
in rats showed higher tissue concentrations than in blood for oral, intravenous, as well as dermal exposure routes 374 
(Mathews et al., 2013). Furthermore, fetal exposure levels may exceed maternal blood levels (Frederiksen et al., 2008). 375 
Therefore, a concern remains that the developing human may not be sufficiently protected against some of the multiple 376 
endocrine disrupting effects of butylparaben, either alone or in combination with other endocrine disrupting chemicals. 377 
In summary, butylparaben altered AGD, ovary and prostate weights, sperm counts and mammary development, and 378 
thus exerted endocrine disrupting effects on both male and female offspring. Interestingly, gene expression profiling of 379 
testis indicated that some of the male reproductive effects may be related to changes in steroidogenesis.  380 
 381 
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Tables 492 
Table 1. Pregnancy and litter data of dams and offspring exposed to 0, 10, 100 or 500 mg butylparaben/kg bw/day from 493 
GD 7 to PD 22. Data represent group means based on litter means ± SD. 494 
Dams and litters Control 10 mg BP 100 mg BP 500 mg BP 
No. of viable litters  n=16  n=13  n=15  n=17 
Dam BW gain GD 7-21 (g) 78.73±16.6 81.04 ± 17.0 86.13 ± 11.2 75.34 ± 19.2 
Dam BW gain GD 7-PND 1 (g) 15.67 ± 7.6 13.46 ± 7.9 13.83 ± 10.7 9.50 ± 10.0 
Dam BW gain PND 1-17 (g) 31.56 ± 12.3 39.08 ± 1.3 37.33 ± 11.5 36.65 ± 12.7 
Gestation length (days) 22.94 ± 0.3 23.00 ± 0.0 23.0 ± 0.0 23.03 ± 0.3 
% postimplantation loss 8.98 ± 11.2 6.83 ± 6.0 8.9 ± 11.7 5.92 ± 10.6 
% perinatal loss 13.48 ± 17.3 7.37 ± 7.0 8.90 ± 11.7 7.39 ± 12.2 
Litter size  10.00 ± 3.5 11.92 ± 1.9 10.6 ± 3.1 10.47 ± 2.9 
% perinatal deaths 4.50 ± 16.1 0.64 ± 2.3 0.0 ± 0.0 1.67 ± 5.1 
% males 47.45 ± 23.8 49.97 ± 11.5 56.45 ± 12.8 50.45 ± 17.8 
Offspring     
Mean male birth weight (g) 6.41 ± 0.4 6.45 ± 0.4 6.62 ± 0.3 6.31 ± 0.6 
AGD males (mm) 3.96 ± 0.1 3.98 ± 0.1 3.77 ± 0.2** 3.69 ± 0.3*** 
AGDI males (mm/ g-3) 2.13 ± 0.1 2.14 ± 0.1 2.01 ± 0.1*** 2.00 ± 0.1*** 
Mean female birth weight (g) 6.13 ± 0.3 6.04 ± 0.4 6.29 ± 0.3 5.98 ± 0.6 
AGD females (mm) 2.22 ± 0.1 2.16 ± 0.1 2.07 ± 0.1** 2.01 ± 0.2*** 
AGDI females (mm/g-3) 1.22 ± 0.0 1.19 ± 0.1 1.12 ± 0.1** 1.11 ± 0.1*** 
Nipples (areolas) males 0.27 ± 0.35 0.15 ± 0.28 0.33 ± 0.39 0.54 ± 0.72 
Nipples (areolas) females 12.3 ± 0.78 12.3 ± 0.3 12.3 ± 0.28 12.3 ± 0.25 
Mean body weight PD 6 (g) 13.2 ± 1.6 12.4 ± 1.1 12.8 ± 1.4 12.2 ± 1.4 
Mean body weight PD14 (g) 28.6 ± 4.0 26.1 ± 2.5 26.1 ± 4.2 26.6 ± 3.6 
Mean body weight PD 24 (g) 48.3 ± 6.7 44.0 ± 4.5 46.2 ± 6.6 45.8 ± 6.1 
Age at vaginal opening (VO) 31.3 ± 2.8 33.1 ± 3.1 32.5 ± 2.4 33.2 ± 2.9 
Body weight at VO 78.1 ± 13 83.7 ± 14 80.8 ± 15 84.3 ± 13 
Age at preputial separation (PPS) 43.6 ± 1.4 44.1 ± 1.7 44.3 ± 1.9 44.7 ± 2.0 
Body weight at PPS 144 ± 12 148 ± 11 153 ± 13 155 ± 16 
 495 
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Table 2. Body and organ weights in rat offspring following perinatal exposure to butylparaben. Asterisks indicate 497 
statistically significant difference from control group. *: p<0.05, **: p<0.01, ***: p<0.001. 498 
   Control Butylparaben 10 Butylparaben 100 Butylparaben 500 
PD 16 males 
N 12 13 14 18 
Body weight (g) 32 ± 5.0 30 ± 2.6 29 ± 4.4 30 ± 5.1 
Liver (mg) 848 ± 167 796 ± 104 748 ± 142 805 ± 154 
Retroperitoneal fat pad (mg) 49.7 ± 21.5 45.6 ± 10.9 42.5 ± 14.8 47.9 ± 18.4 
Right testis (mg) 54.0 ± 9.3 56.4 ± 8.1 52.3 ± 8.6 54.0 ± 9.6 
Left testis (mg) 55.6 ± 8.4 57.9 ± 7.9 52.9 ± 9.5 54.4 ± 9.5 
Ventral prostate (mg) 12.5 ± 2.7 12.0 ± 2.4 12.2 ± 3.7 12.4 ± 2.8 
Seminal vesicle (mg) 7.93 ± 2.79 8.60 ± 2.16 9.32 ± 2.96 8.36 ± 1.87 
Epididymis (mg) 24.7 ± 3.9 24.8 ± 3.3 24.4 ± 4.2 25.2 ± 3.8 
LABC (mg) 27.7 ± 3.6 30.1 ± 5.7 29.8 ± 7.9 32.5 ± 8.8 
Bulbourethral gland (mg) 1.67 ± 0.37 2.02 ± 0.65 1.99 ± 0.48 1.95 ± 0.37 
Adrenal (mg) 10.1 ± 2.9 9.5 ± 0.9 9.0 ± 2.2 9.8 ± 2.0 
PD 17 females 
N 14 13 14 17 
Body weight (g) 34 ± 4.6 30 ± 3.9 31 ± 4.2 32 ± 5.0 
Liver (mg) 931 ± 143 819 ± 112 843 ± 128 867 ± 173 
Retroperitoneal fat pad (mg) 38.1 ± 12.0 29.5 ± 13.1 31.7 ± 13.8 37.0 ± 14.8 
Right ovary (mg) 3.58 ± 0.68 3.29 ± 0.63 2.91 ± 0.72 2.72 ± 0.65** 
Left ovary (mg) 3.93 ± 0.61 3.45 ± 0.54 3.21 ± 0.66* 3.08 ± 0.60*** 
Pooled ovary weight (mg) 7.51 ± 1.19 6.74 ± 1.02 6.13 ± 1.27* 5.80 ± 1.21*** 
Thyroid (mg) 5.14 ± 1.01 5.34 ± 1.42 5.71 ± 1.70 5.45 ± 1.94 
PD 22 males 
N 11 12 13 14 
Body weight (g) 45 ± 6.7 46 ± 4.6 46 ± 4.0 47 ± 6.0 
Right testis (mg) 116 ± 14 125 ± 17 124 ± 11 124 ± 20 
Left testis (mg) 116 ± 15 125 ± 16 125 ± 12 124 ± 19 
Prostate (mg) 30.8 ± 3.9 31.5 ± 3.5 34.3 ± 5.7 34.5 ± 5.0 
PD 22 females 
N 14 13 12 13 
Body weight (g) 45 ± 5.5 44 ± 4.4 46 ± 4.9 43 ± 3.8 
Right ovary (mg) 7.59 ± 0.95 7.90 ± 1.20 8.28 ± 0.81 8.48 ± 1.30 
Left ovary (mg) 7.76 ± 1.37 7.70 ± 0.99 8.01 ± 0.86 8.37 ± 1.24 
PD 80-90 males 
N 16 14 15 18 
Body weight (g) 339 ± 26.8 327 ± 23.5 333 ± 27.8 336 ± 33.7 
Liver (g) 10.9 ± 1.1 10.7 ± 1.1 10.8 ± 1.5 10.6 ± 1.2 
Retroperitoneal fat pad (g) 2.09 ± 0.6 1.69 ± 0.60 1.87 ± 0.48 2.17 ± 0.93 
Right testis (g) 1.75 ± 0.17 1.70 ± 0.11 1.81 ± 0.20 1.77 ± 0.15 
Left testis (g) 1.79 ± 0.15 1.76 ± 0.15 1.86 ± 0.19 1.82 ± 0.15 
Ventral prostate (g) 0.51 ± 0.08 0.47± 0.10 0.48 ± 0.10 0.44 ± 0.08* 
Seminal vesicle with prostate (g) 2.29 ± 0.31 2.12 ± 0.31 2.21 ± 0.32 2.00 ± 0.20* 
LABC (g) 0.965 ± 0.161 0.945 ± 0.097 0.939 ± 0.120 0.892 ± 0.082 
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Bulbourethral gland (g) 0.107 ± 0.020 0.113 ± 0.017 0.098 ± 0.024 0.097 ± 0.020 
Adrenal (g) 0.508 ± 0.040 0.513 ± 0.043 0.547 ± 0.050 0.509 ± 0.045 
PD 80-90 females 
N 15 14 16 18 
Body weight (g) 218 ± 14.5 209 ± 14.8 215 ± 11.8 214 ± 15.9 
Liver (g) 6.57 ± 0.68 6.31 ± 0.59 6.60 ± 0.65 6.75 ± 0.68 
Retroperitoneal fat pad (g) 1.14 ± 0.27 0.92 ± 0.27 1.00 ± 0.25 1.00 ± 0.25 
Right ovary(g) 0.048 ± 0.009 0.043 ± 0.004 0.045 ± 0.004 0.046 ± 0.006 
Left ovary (g) 0.045 ± 0.007 0.042 ± 0.004 0.049 ± 0.008 0.045 ± 0.007 
Uterus (g) 0.396 ± 0.061 0.382 ± 0.059 0.404 ± 0.046 0.394 ± 0.061 
Thyroid (g) 0.023 ± 0.009 0.018 ± 0.004 0.018 ± 0.003 0.018 ± 0.007 
 499 
 500 
  501 
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Table 3. Comparison of studies examining effects of perinatal exposure to butyl- or isobutyl paraben in rats. AGD: anogenital distance, GD: gestation day; PND: 502 
postnatal day; NOAEL: no-observed adverse effect level. 503 
 Chemical Study design Effects on body weight, AGD, sperm count, 
sperm motility, pubertal onset 
Remarks and other effects. Reference 
Butylparaben Subcutaneous exposure of 
Sprague Dawley rats from GD 6 
to PND 20.  
0, 100 or 200 mg/kg bw/day. 
Vehicle: DMSO. 
N=6 control litters, 8 BP litters. 
5-7 per sex per litter killed at 
PND 21, 49, 70 and 90. 
From 100 mg/kg: Reduced female pup body weight 
at PND 49, 70 and 90. Reduced epididymal sperm 
count and sperm motility at PND 90 (n=5). 
 
No effect on male or female AGD at PND 1 (0.05 
mm accuracy). Early vaginal opening at 100 mg/kg 
only. No data on age at preputial separation. 
 
No NOAEL was obtained. 
Reduction of sperm count to ≈50% of 
controls; same effect size at both doses. 
 
Reduced number of live pups from 100 
mg/kg. Reduced pup survival to weaning 
at 200 mg/kg.  
Decreased weight of testes, seminal 
vesicles and prostate in 100 mg/kg dose 
group at some ages only.  
Kang et 
al., 2002 
Butylparaben Oral exposure of Wistar rats 
from GD 7 to PND 21.  
0, 64, 160, 400 or 1000 mg/kg 
bw/day. Vehicle: Corn oil. 
N=7-8 litters. 7-8 males per dose 
group were killed at PND 21, 35, 
49, 90 and 180. 
From 400 mg/kg: Reduced male pup body weight at 
several ages. Shortened male AGD on PND 1 and 
21. Delayed preputial separation. Reduced 
epididymal sperm count and daily sperm 
production.  
 
No examination of sperm motility. 
 
NOAEL 160 mg/kg. 
Slight reduction in sperm count at 160 
mg/kg, but same effect size (reduction to 
64% of controls) at 160 and 400 mg/kg.  
 
Male serum hormone levels: decreased 
testosterone, increased estradiol and 
progesterone, and increased/decreased LH 
and FSH depending on age and dose level 
starting from 400 mg/kg.  
Zhang et 
al., 2014 
Isobutylparaben Oral exposure of Sprague 
Dawley rats from GD 6 to PND 
21. 
0 or 2.5 mg/kg bw/day (in a 
study including also bisphenol 
A). Vehicle: corn oil. 
N=3 litters. 8 males per dose 
groups (representing 3 litters) 
were killed at PND 70. 
At 2.5 mg/kg: Reduced epididymal sperm count and 
sperm motility (n=5). 
 
No change in male pup body weight, male AGD or 
age at preputial separation. 
 
No NOAEL was obtained. 
Small study, one dose of isobutylparaben 
only.  
Reduction of sperm count to ≈40% of 
controls. 
 
Reduced male serum estradiol at PND 70. 
No changes in testis or epididymis weight 
at PND 70. 
Yang et 
al., 2015 
Butylparaben Oral exposure of Wistar rats 
from GD 7 to PND 21. 0, 10, 
100 or 500 mg/kg bw/day. 
Vehicle: corn oil. 
N=18 litters. One male and one 
female pup per litter killed at 
each of three ages: PND 16-17, 
22, and 80-90. 
From 10 mg/kg: Reduced epididymal sperm count. 
From 100 mg/kg: Shortened male and female AGD. 
 
No effect on pup body weight, age at preputial 
separation or age at vaginal opening. No 
examination of sperm motility. 
 
No NOAEL was obtained. 
Reduction of sperm count to 76-78% of 
controls; same effect size at all doses. 
 
Reduced ovary weight at PND 17 from 
100 mg/kg, reduced prostate weight at 
PND 90 at 500 mg/kg, altered mammary 
gland development from 100 mg/kg.  
No effect on nipple retention of males. 
Current 
study 
50
51
52
53
54
55
56
57
58
59
60
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Figure 1. Morphological effects in butylparaben-exposed rats. A, B) Perinatal exposure to 100 504 
or 500 mg/kg bw/day of butylparaben caused shortened AGD in both male and female offspring 505 
relative to control animals. C, D) Ovary weights were reduced at PD 17, but not at PD 22, following 506 
perinatal exposure to 100 or 500 mg/kg bw/day of butylparaben. E, F) The weights of ventral 507 
prostate, total seminal vesicle and prostate were reduced at PND 90 following perinatal exposure 508 
to 500 mg/kg bw/day of butylparaben. Mean+SEM. *: p<0.05, **: p<0.01, ***: p<0.001. AGD was 509 
analyzed with body weight as a covariate and litter as a random factor; organ weights were 510 
analyzed with body weight as a covariate. n=13-17 litters per dose group.  511 
Figure 2. Relative gene expression levels in PD16 and PD 90 testes from control and 512 
butylparabene-exposed rats. A) At PD 16, relative expression levels of the germ cell marker 513 
Ddx4, Sertoli cell markers Sox9 and Fshr, the Sertoli/Leydig expressed genes Ar and Nr5a1, and 514 
Leydig cell markers Lhr, Cyp11a1, Cyp17a1 and Hsd3b11 were unchanged following exposure to 515 
10, 100 or 500 mg/kg bw/day butylparaben. Expression of Cyp19a1 (aromatase) was significantly 516 
lower in testes from all exposure groups at PD 16. B) In adult testes, the expression of the same 517 
genes was unchanged except for Nr5a1, which was lower in testes from all exposed groups 518 
compared to controls. Relative expression levels are shown with mean value of control testes set 519 
to 1, with data normalized using the geometric mean of Rpl13a and Sdha (prepubertal, n=9-10; 520 
adult, n=4; Mean ± SEM; *p<0.05).  521 
Figure 3. Number of sperm per gram cauda in male rats exposed to 0; 10; 100 and 500 mg 522 
butylparaben/kg bw/day from GD 7 to PD 22. Group mean values ± SD are shown, n = 13-17. 523 
Sperm count is significantly lower, indicated by *** with p < 0.0001, in all dosed groups compared 524 
to the control group. 525 
 526 
Figure 4. Effects of perinatal butylparaben exposure of rats on early prostate and mammary 527 
gland development.  A, B) Morphometric analysis revealed a reduced epithelial area (as a 528 
percentage of total prostate area) and reduced epithelium to lumen ratio in PD 22 male offspring 529 
from the middle dose group. Data represents group means +SEM, n=11-14. Asterisks indicate 530 
statistically significant differences from controls analyzed in ANOVA followed by Dunnett’s test, *: 531 
p<0.05; **: p<0.01. C, D) Ventral prostate histology at PD 22, bars indicate 50 µm. Control animals 532 
(C) had columnar epithelium in ventral prostate, whereas enlarged acini with reduced epithelial 533 
height were seen mainly in the middle dose group (D). E) Outgrowth of female mammary glands, 534 
measured as the distance from the mammary gland to nearest lymph node, was increased in 535 
animals exposed to 100 mg/kg bw/day butylparaben. F) The number of terminal end buds in 536 
females was increased at 100 and 500 mg/kg bw/day. Data points indicate measurements from 537 
individual animals with lines representing group means. ** indicate a statistically significant 538 
difference from controls with p<0.01 analyzed by Kruskal-Wallis’ nonparametric test followed by 539 
Dunn’s post test for multiple comparisons. N=12-14. G) Representative mammary whole mount 540 
image of a PD 22 control female mammary gland. H) Representative mammary whole mount 541 
image of a PD 22 high dose female mammary gland with an increased number of Terminal End 542 
Buds (TEB, black arrows). I) Mammary duct from a PD 90 control female. J) Intraductal 543 
hyperplasia (double-headed arrow) in mammary gland from a PD 90 female from the low-dose 544 
group.  545 
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Figure 1. Morphological effects in butylparaben-exposed rats. A, B) Perinatal exposure to 100 or 500 mg/kg 
bw/day of butylparaben caused shortened AGD in both male and female offspring relative to control animals. 
C, D) Ovary weights were reduced at PD 17, but not at PD 22, following perinatal exposure to 100 or 500 
mg/kg bw/day of butylparaben. E, F) The weights of ventral prostate, total seminal vesicle and prostate 
were reduced at PND 90 following perinatal exposure to 500 mg/kg bw/day of butylparaben. Mean+SEM. *: 
p<0.05, **: p<0.01, ***: p<0.001. AGD was analyzed with body weight as a covariate and litter as a 
random factor; organ weights were analyzed with body weight as a covariate. n=13-17 litters per dose 
group.  
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Figure 2. Relative gene expression levels in PD16 and PD 90 testes from control and butylparabene-exposed 
rats. A) At PD 16, relative expression levels of the germ cell marker Ddx4, Sertoli cell markers Sox9 and 
Fshr, the Sertoli/Leydig expressed genes Ar and Nr5a1, and Leydig cell markers Lhr, Cyp11a1, Cyp17a1 and 
Hsd3b11 were unchanged following exposure to 10, 100 or 500 mg/kg bw/day butylparaben. Expression of 
Cyp19a1 (aromatase) was significantly lower in testes from all exposure groups at PD 16. B) In adult testes, 
the expression of the same genes was unchanged except for Nr5a1, which was lower in testes from all 
exposed groups compared to controls. Relative expression levels are shown with mean value of control 
testes set to 1, with data normalized using the geometric mean of Rpl13a and Sdha (prepubertal, n=9-10; 
adult, n=4; Mean ± SEM; *p<0.05).  
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Figure 3. Number of sperm per gram cauda in male rats exposed to 0; 10; 100 and 500 mg butylparaben/kg 
bw/day from GD 7 to PD 22. Group mean values ± SD are shown, n = 13-17. Sperm count is significantly 
lower, indicated by *** with p < 0.0001, in all dosed groups compared to the control group.  
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Figure 4. Effects of perinatal butylparaben exposure of rats on early prostate and mammary gland 
development.  A, B) Morphometric analysis revealed a reduced epithelial area (as a percentage of total 
prostate area) and reduced epithelium to lumen ratio in PD 22 male offspring from the middle dose group. 
Data represents group means +SEM, n=11-14. Asterisks indicate statistically significant differences from 
controls analyzed in ANOVA followed by Dunnett’s test, *: p<0.05; **: p<0.01. C, D) Ventral prostate 
histology at PD 22, bars indicate 50 µm. Control animals (C) had columnar epithelium in ventral prostate, 
whereas enlarged acini with reduced epithelial height were seen mainly in the middle dose group (D). E) 
Outgrowth of female mammary glands, measured as the distance from the mammary gland to nearest 
lymph node, was increased in animals exposed to 100 mg/kg bw/day butylparaben. F) The number of 
terminal end buds in females was increased at 100 and 500 mg/kg bw/day. Data points indicate 
measurements from individual animals with lines representing group means. ** indicate a statistically 
significant difference from controls with p<0.01 analyzed by Kruskal-Wallis’ nonparametric test followed by 
Dunn’s post test for multiple comparisons. N=12-14. G) Representative mammary whole mount image of a 
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PD 22 control female mammary gland. H) Representative mammary whole mount image of a PD 22 high 
dose female mammary gland with an increased number of Terminal End Buds (TEB, black arrows). I) 
Mammary duct from a PD 90 control female. J) Intraductal hyperplasia (double-headed arrow) in mammary 
gland from a PD 90 female from the low-dose group.  
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